News

Two grants on imaging projects go to IMBA

Researchers from IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – are granted funding for two projects from the…

Read more

Valneva Completes Delisting from the Vienna Stock Exchange

Valneva SE confirmed today that it has completed the delisting of its ordinary and preferred shares from the Vienna Stock Exchange (“VSE”). Valneva…

Read more

Phenaris wins 3rd place at i2b Businessplan Competition

Phenaris announced another big success accomplished with ToxPHACTS shortly before the end of the year, as they won won the 3rd place at the i2b…

Read more

Moonstruck worms: how lunar cycles affect metabolic decisions

All organisms need to adjust their energy consumption in response to internal and external signals, thereby allocating energy to growth, reproduction…

Read more

Valneva Appoints MVM Partner Thomas Casdagli to its Supervisory Board

Valneva announced the appointment of MVM Partner Thomas Casdagli to its Supervisory Board. Mr. Casdagli is replacing Dr. Bali Muralidhar as MVM…

Read more

Ares Genetics Joins NVIDIA Inception and AWS Activate Programs

Curetis, a developer of next-level molecular diagnostic solutions, announced that its fully-owned subsidiary Ares Genetics has joined the NVIDIA…

Read more

“ERC-Hattrick” for IMBA Group leader Stefan Ameres

Stefan Ameres, group leader at IMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences- could secure a prestigious ERC…

Read more

Valneva Appoints Renowned Vaccinologists Stanley Plotkin and Anna Durbin to its Scientific Advisory Board

Valneva announced the appointment of two leading vaccine experts to its Scientific Advisory Board (SAB). Dr. Stanley A. Plotkin, MD and Dr. Anna…

Read more

Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference

Valneva announced today that its management team including Thomas Lingelbach, CEO, David Lawrence, CFO, and Franck Grimaud, CBO, will hold media,…

Read more

Three Special Research Programme grants for Vienna BioCenter scientists

The highly collaborative environment of the Vienna BioCenter is once again demonstrated by three new Special Research Programmes (SFBs) going to…

Read more
Interdisciplinary panel discussion. ©Paul Pipernig

A large-scale public event bridging science and society

On December 2nd, a large-scale public event, organized by the City of Vienna in cooperation with the Vienna BioCenter took place in the Globe Theater.…

Read more

Putting a Lid on Multidrug Resistance

Multidrug resistance (MDR) is a fundamentally important medical phenomenon that undermines anticancer and anti-infective therapy of cancer or…

Read more